Tefludazine

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameTefludazine

Drug Alias NameLu-18012

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 2c (5-HT2c) receptor inverse agonistsSerotonin 2a (5-HT2a) receptor inverse agonistsDopamine D3 receptor antagonists +[6]

TargetsSerotonin 2b (5-HT2b) receptorSerotonin 2a (5-HT2a) receptorSerotonin 2c (5-HT2c) receptor +[6]

Therapy Area/IndicationsMental Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesH. Lundbeck A/S

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesH. Lundbeck A/S

Active IndicationsN/A

Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A